Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Unknown 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Uterine Cervical Neoplasms 5Medulloblastoma 5Neuroblastoma 4Squamous Cell Carcinoma of Head and Neck 3Mouth Neoplasms 3Laryngeal Neoplasms 3Hypopharyngeal Neoplasms 3Ganglioneuroblastoma 3Carcinoma 3Vulvar Neoplasms 2Gallbladder Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Vomiting 1Teratoma 1Stage III Nasal Cavity and Paranasal Sinus Squamous Cell Carcinoma AJCC v6 and v7 1Stage I Nasopharyngeal Keratinizing Squamous Cell Carcinoma AJCC v7 1Sertoli-Leydig Cell Tumor 1Rhabdoid Tumor 1Recurrent Uterine Corpus Carcinoma 1Ovarian gynandroblastoma 1Ovarian Neoplasms 1Osteosarcoma 1Oropharyngeal Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Nausea 1Lymphoid Interstitial Pneumonia 1Hodgkin Disease 1Hepatoblastoma 1HIV Infections 1Granulosa cell tumor of the ovary 1

Interventions

Taxes 2Radiotherapy 2Radiation 2Paclitaxel 2Cisplatin 2Platinum 1Carboplatin 1Brachytherapy 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NETWORK × Endometrial Clear Cell Adenocarcinoma × 1,2-diaminocyclohexaneplatinum II citrate × Clear all
NCT00942357 2021-10-19

Carboplatin and Paclitaxel With or Without Cisplatin and Radiation Therapy in Treating Patients With Stage I, Stage II, Stage III, or Stage IVA Endometrial Cancer

GOG Foundation

Phase 3 Unknown
813 enrolled 14 charts
Gynecologic

Endometrial Clear Cell Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡